Dietary Supplements Market Research Reports & Industry Analysis
Dietary supplements are regulated by the Food and Drug Administration’s (FDA) Center for Food Safety and Applied Nutrition (CFSAN). Except in the case of a new dietary ingredient, dietary supplements do not need approval by the FDA before being marketed. Under DSHEA, manufacturers must assure that the dietary supplements it manufactures or distributes are safe and that any claims made about them are demonstrated by sufficient data to show that they are not false or misleading.
DSHEA influences the manufacture of dietary supplements by setting forth a number of rules and guidelines. These include: the establishment of a new plan for assuring safety, nutrition and ingredient labeling specifications, outlining directives for marketing literature, regulation for the use of claims and nutritional support statements, and grant to the FDA the authority to establish good manufacturing practice (GMP) regulations.
Dietary Supplements Industry Research & Market Reports
-
Water-Soluble Vitamin and Mineral Feed Supplements
... reach US$8.8 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Vitamin B3, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach ... Read More
-
Probiotics Dietary Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by the end of ... Read More
-
Heart Healthy Ingredients
... at a CAGR of 4.2% over the analysis period 2024-2030. Omega-3 Ingredient, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$12.4 Billion by the end of ... Read More
-
Food Amino Acids
... at a CAGR of 7.5% over the analysis period 2024-2030. Glutamic Acid, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$4.4 Billion by the end of ... Read More
-
Sports Nutrition Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Amino Acids / Derivatives, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.6 Billion by the ... Read More
-
Animal Proteins
... CAGR of 6.9% over the analysis period 2024-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.6 Billion by the end of ... Read More
-
Calcium Phosphate
... CAGR of 4.5% over the analysis period 2024-2030. Dicalcium Phosphate, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$814.3 Million by the end of the analysis ... Read More
-
Weight Loss Supplements
... at a CAGR of 15.1% over the analysis period 2024-2030. Vitamins & Minerals Ingredient, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$79.9 Billion by the ... Read More
-
Antioxidants
... 5.7% over the analysis period 2024-2030. Synthetic Antioxidants, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth ... Read More
-
Bioactive Materials
... CAGR of 9.0% over the analysis period 2024-2030. Glass Material, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$3.2 Billion by the end of the analysis ... Read More
-
Botanical Supplements
... CAGR of 8.0% over the analysis period 2024-2030. Spices, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$22.3 Billion by the end of the analysis period. ... Read More
-
Phytosterols
... 7.7% over the analysis period 2024-2030. Beta-sitosterol, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in ... Read More
-
Polyphenols
... 7.2% over the analysis period 2024-2030. Functional Beverages Application, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$855.9 Million by the end of the analysis period. ... Read More
-
D-Mannose
... 3.8% over the analysis period 2024-2030. D-Mannose Capsule, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$592.9 Million by the end of the analysis period. Growth ... Read More
-
Vitamin Fortified and Mineral Enriched Food & Beverage
... 2024, is expected to reach US$123.0 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Foods Application, one of the segments analyzed in the report, is expected to record a ... Read More
-
Herbal Supplements and Remedies
... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Multi-Herb Supplements and Remedies, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$94.2 Billion ... Read More
-
Cosmetic Antioxidants
... CAGR of 5.0% over the analysis period 2024-2030. Vitamins, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$54.2 Million by the end of the analysis period. ... Read More
-
Fish Oil Products
... at a CAGR of 3.4% over the analysis period 2024-2030. Blue Whiting Species, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$811.9 Million by the end ... Read More
-
Glycinates
... 5.0% over the analysis period 2024-2030. Magnesium Glycinate, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$732.0 Million by the end of the analysis period. Growth ... Read More
-
Galacto-oligosaccharide (GOS)
... CAGR of 6.5% over the analysis period 2024-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$830.9 Million by the end of ... Read More
-
Synbiotic Products
... CAGR of 7.1% over the analysis period 2024-2030. Functional Food & Beverages, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Vitamin and Mineral Premixes
... 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Powder Form, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$9.6 Billion by the ... Read More
-
Bone and Joint Health Supplements
... Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Joint Supplements, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$14.4 Billion ... Read More
-
Vitamin D Therapy
... at a CAGR of 11.7% over the analysis period 2024-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$5.9 Billion by the end of ... Read More
-
Voice of the Consumer: Consumer Health 2024
... and generic OTCs, the rise of holistic health, and the evolution of the vitamins and dietary supplements space. Euromonitor International’s Voice of the Consumer: Consumer Health 2024 global briefing examines the size, growth trends and ... Read More
Research Assistance
